Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pasireotide 40 MG Injection

Known as: PASIREOTIDE 40MG/KIT SA INJ SUSP, PASIREOTIDE 40MG/KIT INJ,SUSP,SA [VA Product], pasireotide LAR 40 MG Injection 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Acromegaly is a rare disease due to chronic excess growth hormone (GH) and IGF-1. Aryl hydrocarbon receptor interacting protein… Expand
Is this relevant?
2018
2018
PurposeMedullary thyroid cancer (MTC) is a neuroendocrine tumour of the thyroid C cells. Pasireotide, a multi-receptor targeted… Expand
  • table 2
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
2017
2017
BACKGROUND Long-term medical management of hypersomatotropism (HS) in cats has proved unrewarding. Pasireotide, a novel… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Review
2016
Review
2016
Pasireotide (Signifor®) long-acting release (LAR) is a next-generation somatostatin receptor ligand (SRL) approved for treatment… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Objective:A subset of meningiomas recur after surgery and radiation therapy, but no medical therapy for recurrent meningioma has… Expand
Is this relevant?
2015
2015
PurposePasireotide LAR (SOM230 LAR) is a cyclohexapeptide engineered to bind to multiple somatostatin receptor subtypes to mimic… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2014
2014
PurposeA large, randomized, double-blind, Phase III core study demonstrated that pasireotide LAR was significantly superior to… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2014
2014
241 Background: Pasireotide LAR is a novel somatostatin analog (SSA) with avid binding to somatostatin receptor subtypes (SSTR) 1… Expand
Is this relevant?
2012
2012
Background: Lymphocele is the principal post-operative morbidity following axillary node dissection. According to the literature… Expand
Is this relevant?
2011
2011
2040 Background: Patients with recurrent or progressive meningiomas who have exhausted surgical and radiation options have… Expand
Is this relevant?